Retrograde delivery of pharmacologic and diagnostic agents via venous circulation

• US 4,689,041 A
• Filed: 10/09/1985
• Issued: 08/25/1987
• Est. Priority Date: 01/20/1984
• Status: Expired due to Term

• Current Assignee: Zoll Circulation Incorporated (Asahi Kasei Corporation), Heartport, Inc. (Johnson & Johnson), Retroperfusion Systems, Inc.
• Original Assignee: Eliot Corday
• Inventors: Meerbaum, Samuel, Corday, Eliot
• Primary Examiner(s): Rosenbaum, C. Fred
• Assistant Examiner(s): Ferros, John D.
• Application Number:
  US06/785,840
• Time in Patent Office: 685 Days
• Field of Search: 604/99, 604/96, 604/97, 604/98, 604/53, 604/280, 604/281, 128/344
• US Class Current: 604/509
• CPC Class Codes: A61M 2025/1052 for temporarily occluding a vessel for isolating a sector
• CPC Class Codes: A61M 25/1002 characterised by balloon shape A61M25/1006, A61M25/1009 take precedence

Abstract

This invention is directed to specific methods and a system for the retrograde delivery of fluids containing a pharmacologic or diagnostic agent (via a catheter inserted into a patient'"'"'s regional venous system) supplied into the microcirculatory system of the same region to which the arterial blood in flow is blocked or otherwise restricted. A catheter having an inflatable balloon on the distal end thereof is passed through the patient'"'"'s venous system (e.g., for myocardial retroinfusion, and so that fluid containing pharmacologic (thrombolytic drugs or antiarrhythmic agents) or diagnostic agents is directed therethrough in a direction opposite to the normal blood flow and into the microcirculatory system of the jeopardized tissue. The fluid is held in the microcirculation for a period and at a pressure which facilitates its absorption or other function such as clot dissolution, pharmacologic action, or diagnostic contrast assessment with minimally invasive imaging methods. The balloon is then deflated after a particular treatment period, or else retroinfusion is reduced or terminated whenever the fluid pressure in the regional vein exceeds a predetermined maximal pressure which could lead to tissue damage. For coronary venous retroinfusion, the catheter tip balloon when inflated has preferably a broad base and tapers in the distal direction to the apex thereof.

Claims

1. A method for the retrograde venous delivery of fluid containing pharmacologic or diagnostic agents to a microcirculatory system in a desired location within a patient'"'"'s body comprising:

a. inserting a catheter having an inflatable balloon at the distal end thereof into the patient'"'"'s venous system and advancing the catheter to a position within a vein which drains the microcirculatory system;

b. inflating the balloon at the distal end of the catheter to thereby block the interior of the vein and prevent fluid from flowing through the vein in the same direction as normal blood flow;

c. directing the fluid containing pharmacologic or diagnostic agents through the catheter and the vein and into the microcirculatory system in a retrograde direction which is opposite to the normal blood flow therethrough;

d. maintaining the fluid containing pharmacologic or diagnostic agents in the microcirculatory system for a period of time of at least two seconds and at sufficient pressure to facilitate the delivery of the fluid in an unsynchronized manner to the desired location and the desired performance of the pharmacologic or diagnostic agents contained therein; and

e. deflating the balloon at the distal end of the catheter to allow fluid to drain from the microcirculatory system through the vein in the direction of normal blood flow therein.

2. The method of claim 1, wherein the fluid containing the pharmacologic or diagnostic agent is held in the microcirculatory system for a minimum period of from about 2 seconds to about 10 minutes.

3. The method of claim 1, wherein the distal end of the catheter is inserted into the patient'"'"'s coronary sinus to instill the fluid containing pharmacologic or diagnostic agents to a microcirculatory system in the patient'"'"'s myocardium.

4. The method of claim 3, wherein the inflated balloon at the distal end of the catheter has a broad base and a tapered apex.

5. The method of claim 4, wherein the inflated balloon has the shape of an acorn.

6. The method of claim 4, wherein the distal end of the catheter is positioned within the coronary sinus so that the inflated balloon does not obstruct the middle cardiac vein.

7. The method of claim 3, wherein the fluid delivered to the microcirculatory system contains one or more pharmacologic agents selected from the group consisting of antiarrhythmic drugs, spasmolytic drugs, thrombolytic drugs, anti-inflammatory drugs, inotropic drugs, vasodilating drugs, cardioplegic drugs.

8. The method of claim 7, wherein the fluid contains one or more drugs selected from the group consisting of prostaglandins, mannitol, streptokinase, lidocaine, procainamide, verapamil, propranolol, disopyramide, amiodarone, cardiazem, nifedipine, dipyridamole, novocaine, aminophyllin, digitalis, catecholamines, steriods, and glucose-insulin-potassium mixtures.

9. The method of claim 3, wherein the fluid contains a diagnostic contrast agent employed for aniography, radionuclide imaging or echocardiographic imaging.

10. The method of claim 3, wherein fluid is directed through the catheter, the coronary sinus and into the microcirculatory system in the patient'"'"'s myocardium when the heart is in diastole.

11. The method of claim 1, wherein the inflated balloon at the distal end fo the catheter is deflated when the fluid pressure exceeds a predetermined maximum to allow fluid drainage through the vein in the normal direction thereby relieving excessive pressure.

12. The method of claim 1, wherein after fluid has been maintained in the microcirculatory system for at least about two seconds, the fluid pressure in the catheter is released to deflate the inflated balloon to allow for normal venous drainage.

13. The method of claim 12, wherein the period for normal venous drainage is at least 5 minutes.